Page last updated: 2024-10-29
avapro and Shock
avapro has been researched along with Shock in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Nielsen, EW | 1 |
Other Studies
1 other study available for avapro and Shock
| Article | Year |
|---|---|
Hypotensive shock and angio-oedema from angiotensin II receptor blocker: a class effect in spite of tripled tryptase values.
Topics: Angioedema; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Biphenyl Compounds; Female; Humans; | 2005 |